RU2017138067A3 - - Google Patents

Download PDF

Info

Publication number
RU2017138067A3
RU2017138067A3 RU2017138067A RU2017138067A RU2017138067A3 RU 2017138067 A3 RU2017138067 A3 RU 2017138067A3 RU 2017138067 A RU2017138067 A RU 2017138067A RU 2017138067 A RU2017138067 A RU 2017138067A RU 2017138067 A3 RU2017138067 A3 RU 2017138067A3
Authority
RU
Russia
Application number
RU2017138067A
Other languages
Russian (ru)
Other versions
RU2017138067A (ru
RU2716218C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017138067A publication Critical patent/RU2017138067A/ru
Publication of RU2017138067A3 publication Critical patent/RU2017138067A3/ru
Application granted granted Critical
Publication of RU2716218C2 publication Critical patent/RU2716218C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2017138067A 2015-05-06 2016-05-06 Состав для инъекции на основе жировой эмульсии кабазитаксела, способ его получения и применение RU2716218C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510227743.7 2015-05-06
CN201510227743.7A CN106176599A (zh) 2015-05-06 2015-05-06 一种卡巴他赛脂肪乳注射剂及其制备方法
PCT/CN2016/081245 WO2016177346A1 (zh) 2015-05-06 2016-05-06 一种卡巴他赛脂肪乳注射剂及其制备方法和用途

Publications (3)

Publication Number Publication Date
RU2017138067A RU2017138067A (ru) 2019-05-06
RU2017138067A3 true RU2017138067A3 (de) 2019-05-06
RU2716218C2 RU2716218C2 (ru) 2020-03-10

Family

ID=57218491

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017138067A RU2716218C2 (ru) 2015-05-06 2016-05-06 Состав для инъекции на основе жировой эмульсии кабазитаксела, способ его получения и применение

Country Status (9)

Country Link
US (1) US20180153848A1 (de)
EP (1) EP3292860B1 (de)
JP (1) JP2018515484A (de)
KR (1) KR20180006902A (de)
CN (2) CN106176599A (de)
AU (1) AU2016258642B2 (de)
CA (1) CA2982625A1 (de)
RU (1) RU2716218C2 (de)
WO (1) WO2016177346A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105983016B (zh) 2015-03-23 2023-08-11 天士力医药集团股份有限公司 一种含有水飞蓟宾的药物组合
CN108464970B (zh) * 2018-04-25 2020-11-03 广州暨南生物医药研究开发基地有限公司 一种代谢及外排双抑制型的安五脂素纳米乳及其制备方法
US11679163B2 (en) 2019-09-20 2023-06-20 Hdt Bio Corp. Compositions and methods for delivery of RNA
KR20220156933A (ko) 2020-03-23 2022-11-28 에이치디티 바이오 코포레이션 Rna의 전달을 위한 조성물 및 방법
CN111888332B (zh) * 2020-06-19 2023-07-25 杭州师范大学 一种卡巴他赛柔性乳剂及其制备方法
CN112190547B (zh) * 2020-09-30 2023-01-03 北京诺康达医药科技股份有限公司 脂质微球组合物及其制备方法
WO2023048760A1 (en) 2021-09-22 2023-03-30 Hdt Bio Corp. Rna vaccines against infectious diseases
JP2024535354A (ja) 2021-09-22 2024-09-30 エイチディーティー バイオ コーポレーション がん治療組成物およびその使用
EP4404919A4 (de) 2021-09-22 2025-08-20 Hdt Bio Corp Getrocknete nanopartikelzusammensetzungen
CA3232719A1 (en) 2021-09-22 2023-03-30 Steven Gregory REED Sars-cov-2 rna vaccine compositions and methods of use
CN115778902A (zh) * 2022-12-16 2023-03-14 江苏辅必成医药科技有限公司 一种奥扎格雷脂肪乳注射液及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101019832A (zh) * 2007-03-19 2007-08-22 沈阳药科大学 多西他赛脂肪乳剂及其冻干剂与制备方法
CA2731353A1 (en) * 2008-07-23 2010-02-18 Bharat Serums & Vaccines Ltd. Stable injectable oil-in-water docetaxel nanoemulsion
CN102008434B (zh) * 2009-09-04 2012-05-30 辽宁万嘉医药科技有限公司 复方多烯紫杉醇脂微球注射液及其制备方法
US20120065255A1 (en) * 2009-10-19 2012-03-15 Nagesh Palepu Cabazitaxel formulations and methods of preparing thereof
US20110166214A1 (en) * 2010-01-07 2011-07-07 Innopharma, Llc Methods and compositions for delivery of taxanes in stable oil-in-water emulsions
US10842770B2 (en) * 2010-05-03 2020-11-24 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN103006558A (zh) * 2011-12-21 2013-04-03 苏州雷纳药物研发有限公司 一种Cabazitaxel脂质微球注射液及其制备方法
CN104306333B (zh) * 2014-09-28 2017-08-04 沈阳药科大学 一种卡巴他赛脂质微球注射液及其制备方法

Also Published As

Publication number Publication date
CA2982625A1 (en) 2016-11-10
JP2018515484A (ja) 2018-06-14
RU2017138067A (ru) 2019-05-06
EP3292860A1 (de) 2018-03-14
US20180153848A1 (en) 2018-06-07
EP3292860A4 (de) 2018-03-14
WO2016177346A1 (zh) 2016-11-10
KR20180006902A (ko) 2018-01-19
CN106176599A (zh) 2016-12-07
CN107530281A (zh) 2018-01-02
EP3292860B1 (de) 2019-04-17
RU2716218C2 (ru) 2020-03-10
AU2016258642B2 (en) 2020-06-18
AU2016258642A1 (en) 2017-09-07

Similar Documents

Publication Publication Date Title
RU2017138067A3 (de)
BE2015C047I2 (de)
BE2015C044I2 (de)
BR0002694B1 (de)
BR0003166B1 (de)
BR0000763F1 (de)
BR0001536B1 (de)
BR0001684B1 (de)
BR0001810B1 (de)
BR0002033B1 (de)
BR0002402B1 (de)
BR0002435B1 (de)
BR0008158B1 (de)
BR0002802B1 (de)
BR0002874B1 (de)
BR0006634B1 (de)
BR0003189B1 (de)
BR0003208B1 (de)
BR0003401B1 (de)
BR0003686B1 (de)
BR0003746B1 (de)
BR0003751B1 (de)
BR0003928B1 (de)
BR0004687B1 (de)
BR0005041B1 (de)